Magnetic resonance imaging of experimental atherosclerotic plaque: Comparison of two ultrasmall superparamagnetic particles of iron oxide

被引:48
|
作者
Herborn, Christoph U.
Vogt, Florian M.
Lauenstein, Thomas C.
Dirsch, Olaf
Corot, Claire
Robert, Philippe
Ruehm, Stefan G.
机构
[1] Univ Hamburg, Med Ctr, Med Prevent Ctr, D-20251 Hamburg, Germany
[2] Univ Hosp Essen, Dept Diagnost & Intervent Radiol, Essen, Germany
[3] Lab Guerbet, Aulnay Sous Bois, France
[4] Univ Hosp Essen, Dept Pathol, Essen, Germany
[5] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiol, Los Angeles, CA USA
[6] Emory Univ, Sch Med, Dept Radiol, Atlanta, GA USA
关键词
atherosclerosis; magnetic resonance imaging; contrast media; USPIO; animal model;
D O I
10.1002/jmri.20649
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To evaluate a new ultrasmall superparamagnetic particles of iron oxide (USPIO) compound, ferumoxytol, as a marker of macrophage activity in atherosclerotic plaques and to compare it to ferumoxtran-10. Materials and Methods: Ten mature heritable hyperlipidemic (WHHL) female Watanabe rabbits served as the animal model for atherosclerosis, four coeval female New Zealand White (NZW) rabbits were the control group. Five WHHL and two NZW received a single intravenous injection (250 mu mol/kg) of either ferumoxtran-10 or ferumoxytol and were subjected to daily-MR examinations on a 1.5T. whole body scanner for the next five days. Development of signal intensity changes and susceptibility effects was assessed. Statistical analysis was based on a nonparametric Wilcoxon-Mann-Whitney-U test, by using a P value at the 0.05 significance level. On day 5, the rabbits were sacrificed and the aorta was referred to histopathology, distribution of iron particles in the vessel wall was analyzed. Results: MRI was feasible in all animals. Three days after injection of ferumoxytol the highest luminal signal,intensity measurements were observed in the ferumoxytol group; the highest measurements were five days after injection in the ferumoxtran- 10 group, (P < 0.05). In the WHHL, susceptibility effects presented as homogeneous dark lines parallel to the aortic wall after ferumoxytol and spotted areas void of signal after ferumoxtran-10. None of these findings were observed in. the NZW control groups.
引用
收藏
页码:388 / 393
页数:6
相关论文
共 50 条
  • [21] Magnetic Resonance Imaging of Abdominal Aortic Aneurysms (AAA) Using Ultrasmall Superparamagnetic Particles of Iron Oxide (USPIO)
    Richards, Jennifer M.
    Semple, Scott I.
    Gray, Calum
    McKillop, Graham
    Chalmers, Roderick T.
    Garden, Olivier J.
    Newby, David E.
    JOURNAL OF VASCULAR SURGERY, 2010, 51 : 48S - 48S
  • [22] Ultrasmall superparamagnetic iron oxide (USPIO)-based liposomes as magnetic resonance imaging probes
    Frascione, Daniela
    Diwoky, Clemens
    Almer, Gunter
    Opriessnig, Peter
    Vonach, Caroline
    Gradauer, Kerstin
    Leitinger, Gerd
    Mangge, Harald
    Stollberger, Rudolf
    Prassl, Ruth
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2012, 7 : 2349 - 2359
  • [23] Phase characteristic of superparamagnetic iron oxide particles in magnetic resonance imaging
    Zhu, Haitao
    Demachi, Kazuyuki
    INTERNATIONAL JOURNAL OF APPLIED ELECTROMAGNETICS AND MECHANICS, 2010, 33 (1-2) : 721 - 726
  • [24] Phase Characteristic of Superparamagnetic Iron Oxide Particles in Magnetic Resonance Imaging
    Zhu, Haitao
    Demachi, Kazuyuki
    APPLIED ELECTROMAGNETICS AND MECHANICS (II), 2009, 13 : 283 - 284
  • [25] Superparamagnetic iron oxide particles: contrast media for magnetic resonance imaging
    Lawaczeck, R
    Menzel, M
    Pietsch, H
    APPLIED ORGANOMETALLIC CHEMISTRY, 2004, 18 (10) : 506 - 513
  • [26] Lymphatic target volume delineation using magnetic resonance imaging with ultrasmall particles of superparamagnetic iron oxide in carcinoma of the prostate
    Dinniwell, R
    Chan, P
    Haider, M
    Fyles, A
    Kirilova, A
    Syed, A
    Jaffray, D
    Milosevic, M
    RADIOTHERAPY AND ONCOLOGY, 2005, 76 : S28 - S28
  • [27] Comparison of ultrasmall superparamagnetic iron oxide particles and low molecular weight contrast agents to detect rejecting transplanted hearts with magnetic resonance imaging
    Penno, E
    Johnsson, C
    Johansson, L
    Ahlström, H
    INVESTIGATIVE RADIOLOGY, 2005, 40 (10) : 648 - 654
  • [28] Polymer-Lipid Hybrid Theranostic Nanoparticles Co-Delivering Ultrasmall Superparamagnetic Iron Oxide and Paclitaxel for Targeted Magnetic Resonance Imaging and Therapy in Atherosclerotic Plaque
    Dong, Yinmei
    Chen, Huaiwen
    Chen, Chao
    Zhang, Xuefeng
    Tian, Xia
    Zhang, Yingying
    Shi, Zhang
    Liu, Qi
    JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2016, 12 (06) : 1245 - 1257
  • [29] Use of ultrasmall superparamagnetic iron oxide particles for imaging carotid atherosclerosis
    Usman, Ammara
    Sadat, Umar
    Patterson, Andrew J.
    Tang, Tjun Y.
    Varty, Kevin
    Boyle, Jonathan R.
    Armon, Mathew P.
    Hayes, Paul D.
    Graves, Martin J.
    Gillard, Jonathan H.
    NANOMEDICINE, 2015, 10 (19) : 3077 - 3087
  • [30] Clinical evaluation of ultrasmall superparamagnetic iron oxide particles for liver imaging
    Saini, S
    Edelman, RR
    Li, W
    Petersein, J
    Hahn, PF
    ACADEMIC RADIOLOGY, 1996, 3 : S409 - S412